Ryan Salmons Increases Stake in LTCH
LTCH's Chief Prod. & Tech. Officer acquired 500,000 shares.
Key Points
- Ryan Salmons, LTCH's Chief Prod. & Tech. Officer, bought 500,000 shares on June 12, 2026.
- LTCH shares currently trade at $0.18, with insider buying indicating potential confidence.
- Peer funds like Parkwood LLC hold 998,286 shares valued at $210,000.
Ryan Salmons, the Chief Product and Technology Officer at LTCH, recently acquired 500,000 shares of the company on June 12, 2026. The shares were added without a specified purchase price, indicating they might have been awarded rather than bought in the open market. This move showcases a significant increase in his stake in the company.
What Changed in Ryan Salmons' LTCH Position
Salmons' recent acquisition of 500,000 shares marks a notable increase in his holdings in LTCH. The transaction, dated June 12, 2026, was not part of a pre-arranged trading plan, suggesting a direct decision by Salmons to expand his ownership.
Other Institutional Activity in LTCH
Looking at LTCH's institutional investors, Parkwood LLC maintains a strong position with 998,286 shares valued at about $210,000. FNY Investment Advisers, LLC holds a smaller position of 10,001 shares worth approximately $2,000. MassMutual Private Wealth & Trust, FSB has a minimal stake with 537 shares valued at $113. Ancora Advisors LLC, however, has completely exited its position, reducing its holdings by 10 shares to zero.
LTCH Stock Snapshot
LTCH shares are currently trading at around $0.18. The stock has seen varied interest from both insiders and institutional investors, reflecting differing perspectives on its potential.
Insider Buying and Selling at LTCH
On June 12, 2026, Ryan Salmons, LTCH's Chief Product and Technology Officer, not only acquired 500,000 shares but also sold 59,895 shares at an average price of $0.20. David Lillis, the Chief Executive Officer, bought 968,179 shares and sold 257,816 shares at the same average price. Priyen Patel, the Chief Strategy and Legal Officer, sold 3,447 shares on June 3, 2026, at $0.14 per share.
Bottom Line
Ryan Salmons' significant acquisition of LTCH shares could suggest his confidence in the company's future prospects. While the insider buying is noteworthy, it's essential to remember that insider transactions are just one of many factors investors consider. As this transaction was not pre-planned, it may reflect a strategic decision by Salmons. Investors often track such insider activity for potential insights into company performance.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.
